Advanced and Integrative Therapeutic Strategies in Parkinson’s Disease Management offers a comprehensive exploration of the latest innovations and multidisciplinary approaches in Parkinson’s Disease treatment. The volume is organized into sections covering genetic therapies, gut microbiota, artificial intelligence, virtual reality, neuroprotective strategies, polypharmacy, and combination therapies. It addresses the integration of personalized medicine, neuroprotective diets, natural products, cognitive enhancers, and ethical considerations. Additional chapters introduce traditional medicine, music therapy, and the synergy between pharmacotherapy and complementary modalities. The book equips readers with the knowledge to implement innovative therapies, navigate complex ethical landscapes, and integrate multidisciplinary and complementary approaches.
This reference is essential for those seeking to advance clinical practice and research in Parkinson’s Disease through the adoption of cutting-edge strategies.
Highlights advanced and integrative therapeutic strategies for Parkinson’s Disease management
Examines multidisciplinary and complementary approaches to care
Addresses ethical and practical challenges of novel translational therapies
Dr. Wael Mohamed, BSc, MMSc, MD, PhD, FAAS, is Professor, Basic Medical Science Department at the International Islamic University Malaysia (IIUM). He specializes in translational brain research and the development of novel treatments for Alzheimer’s Disease and Parkinson’s Disease.
Section I: Advanced & Precision Therapies1. Genetic Therapies for Parkinson’s Disease: The Dawn of Precision Medicine2. Role of Gut Microbiota in Parkinson’s Disease Pharmacotherapy3. Artificial Intelligence, Machine Learning, Virtual Reality & Gamification in Drug Development4. rTMS as an Adjunct to Pharmacotherapy5. Neuroprotective Therapies6. Polypharmacy and Combination TherapiesSection II: Integration, Cognition & Future Horizons7. Repurposing Existing Drugs for Parkinson’s Disease Management8. Personalized Medicine in Parkinson’s Disease9. Neuroprotective Diets & Synergy with Pharmacotherapy10. Natural Products in Parkinson’s Disease Animal Models11. Cognitive Enhancers in Parkinson’s Disease12. Emerging Targets for Cognitive Enhancement13. Ethical & Practical Challenges with Cognitive Enhancers14. Unani Pharmacotherapy in Parkinson’s Disease15. Music Therapy & Its Synergy with Pharmacotherapy
Advanced and Integrative Therapeutic Strategies in Parkinson’s Disease Management offers a comprehensive exploration of the latest innovations and multidisciplinary approaches in Parkinson’s Disease treatment. The volume is organized into sections covering genetic therapies, gut microbiota, artificial intelligence, virtual reality, neuroprotective strategies, polypharmacy, and combination therapies. It addresses the integration of personalized medicine, neuroprotective diets, natural products, cognitive enhancers, and ethical considerations. Additional chapters introduce traditional medicine, music therapy, and the synergy between pharmacotherapy and complementary modalities. The book equips readers with the knowledge to implement innovative therapies, navigate complex ethical landscapes, and integrate multidisciplinary and complementary approaches.
This reference is essential for those seeking to advance clinical practice and research in Parkinson’s Disease through the adoption of cutting-edge strategies.
Highlights advanced and integrative therapeutic strategies for Parkinson’s Disease management
Examines multidisciplinary and complementary approaches to care
Addresses ethical and practical challenges of novel translational therapies
Dr. Wael Mohamed, BSc, MMSc, MD, PhD, FAAS, is Professor, Basic Medical Science Department at the International Islamic University Malaysia (IIUM). He specializes in translational brain research and the development of novel treatments for Alzheimer’s Disease and Parkinson’s Disease.
Section I: Advanced & Precision Therapies1. Genetic Therapies for Parkinson’s Disease: The Dawn of Precision Medicine2. Role of Gut Microbiota in Parkinson’s Disease Pharmacotherapy3. Artificial Intelligence, Machine Learning, Virtual Reality & Gamification in Drug Development4. rTMS as an Adjunct to Pharmacotherapy5. Neuroprotective Therapies6. Polypharmacy and Combination TherapiesSection II: Integration, Cognition & Future Horizons7. Repurposing Existing Drugs for Parkinson’s Disease Management8. Personalized Medicine in Parkinson’s Disease9. Neuroprotective Diets & Synergy with Pharmacotherapy10. Natural Products in Parkinson’s Disease Animal Models11. Cognitive Enhancers in Parkinson’s Disease12. Emerging Targets for Cognitive Enhancement13. Ethical & Practical Challenges with Cognitive Enhancers14. Unani Pharmacotherapy in Parkinson’s Disease15. Music Therapy & Its Synergy with Pharmacotherapy